Cargando…

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study

OBJECTIVE: Asenapine is a second-generation antipsychotic agent that is classified as a multi-acting receptor-targeted antipsychotic and is similar to olanzapine. Our study aimed to compare the treatment continuation rate and reason for discontinuation of asenapine or olanzapine in schizophrenia usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuzaki, Haruna, Hatano, Masakazu, Iwata, Miko, Yamada, Shigeki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684434/ https://www.ncbi.nlm.nih.gov/pubmed/34934318 http://dx.doi.org/10.2147/NDT.S343840

Ejemplares similares

Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study
por: Matsuzaki, Haruna, et al.
Publicado: (2023)

Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General Population
por: Iwata, Miko, et al.
Publicado: (2023)

Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia
por: Inoue, Yuichi, et al.
Publicado: (2021)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
por: Okazaki, Kosuke, et al.
Publicado: (2017)

A Randomized Controlled Trial to Compare the Efficacy, Safety and Tolerability of Asenapine versus Olanzapine in Management of Schizophrenia
por: Maitra, Arpita, et al.
Publicado: (2020)

Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database
por: Hatano, Masakazu, et al.
Publicado: (2023)

Role of sublingual asenapine in treatment of schizophrenia
por: Citrome, Leslie
Publicado: (2011)

Transdermal Asenapine in Schizophrenia: A Systematic Review
por: Carrithers, Brennan, et al.
Publicado: (2020)

Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
por: Hatano, Masakazu, et al.
Publicado: (2017)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
por: Bishara, Delia, et al.
Publicado: (2009)

Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine
por: Takao, Nagara, et al.
Publicado: (2021)

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
por: Thomas, Jennifer E., et al.
Publicado: (2015)

Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
por: Stepanova, Ekaterina, et al.
Publicado: (2017)

Asenapine for bipolar disorder
por: Scheidemantel, Thomas, et al.
Publicado: (2015)

Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia
por: Tajiri, Misuzu, et al.
Publicado: (2018)

Subjective assessment of brexpiprazole in patients with schizophrenia: a prospective observational study
por: Yokoi, Rina, et al.
Publicado: (2023)

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia
por: Ogyu, Kamiyu, et al.
Publicado: (2020)

A propensity score matching analysis for cardio metabolic risk of antipsychotics in patients with schizophrenia using Japanese claims data
por: Kusumi, Ichiro, et al.
Publicado: (2020)

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
por: Chen, Jian, et al.
Publicado: (2011)

Efficacy of Asenapine in Schizophrenia Resistant to Clozapine Combined with Electroconvulsive Therapy: A Case Report
por: Ochi, Shinichiro, et al.
Publicado: (2019)

Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching
por: Oba, Seiya, et al.
Publicado: (2023)

A Review of Asenapine in the Treatment of Bipolar Disorder
por: Vieta, Eduard, et al.
Publicado: (2017)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
por: Ye, Wenyu, et al.
Publicado: (2011)

Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
por: Lachaine, Jean, et al.
Publicado: (2014)

Safety of Continuing Aspirin Use in Cervical Laminoplasty: A Propensity Score-Matched Analysis
por: Chung Wong, Yu, et al.
Publicado: (2022)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

Asenapine pharmacokinetics and tolerability in a pediatric population
por: Dogterom, Peter, et al.
Publicado: (2018)

Propensity score matching and complex surveys
por: Austin, Peter C, et al.
Publicado: (2016)

Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
por: Hatano, Masakazu, et al.
Publicado: (2021)

Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination Response in Japanese Patients with Autoimmune Hepatitis: Results of Propensity Score-Matched Case–Control Study
por: Moriya, Kei, et al.
Publicado: (2023)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Generalized Propensity Score Matching with Multilevel Treatment Options
por: Baser, Onur
Publicado: (2013)

Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case–control study with propensity score matching
por: Iwata, Tsutomu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rtihs72u62gj8h8bi2lphbj20b